Category Archives: LEDs

August 3, 2005 – Universal Display Corp. has announced the demonstration of a white OLED lighting panel with a record power efficiency of 30 lumens per watt (lm/W) using the company’s PHOLED phosphorescent OLED technology at The International Society for Optical Engineering (SPIE) Symposia and Exhibition held in San Diego, CA.

The company’s white OLED performance is based on a novel panel design that consists of an array of red, green, and blue colored stripes. Adjusting the intensity of each primary color generates infinite shades of white color, typically characterized by color temperature and color rendering index.

Power efficiencies of this 6″ x 6″ prototype panel were measured at color temperatures between 2,900 and 5700K. The 30 lm/W white OLED power efficiency was achieved at a color temperature of 4000K, which is comparable to the color temperature and power efficiency of a cool fluorescent lamp. By comparison, typical incandescent light bulbs emit light at around 15-20 lm/W with a color temperature of 2900K.

This panel can also operate very brightly. For example, this 6″ x 6″ panel produced 150 lumens of optical power, at an efficiency of 15 lm/W and 3700K color temperature.

Increasing the efficiency of lighting by a small amount has the potential to generate tremendous savings in both cost and energy use.

This advance was reported in a paper, “Phosphorescent organic light-emitting devices for solid-state lighting,” presented at the SPIE Optics and Photonics 2005 Symposia, on Monday by Dr. Brian D’Andrade, senior scientist at Universal Display, at the San Diego Convention Center. This work was partially funded by a US Department of Energy Small Business Innovation Research grant.

Aug. 3, 2005 — Materials discovery firm Intematix Corp. of Fremont, Calif. and LED designer and manufacturer Unity Opto Technology Co. Ltd. of Taipei County, Taiwan announced a partnership based on Intematix’ White Lightning Y460 and Y450 phosphors that included a license agreement.

The companies had been in discussions for several months. Unity Opto intends to use the Intematix phosphor to produce new products. The agreement is the latest in a number of partnerships based on the phosphors developed at Intematix.

Aug. 3, 2005 — Nano-Tex, an Emeryville, Calif. provider of nanotechnology-based textile enhancements to the apparel and interior furnishings markets, has added three new people to its North American business development team.

The new hires will focus on driving adoption of Nano-Tex treatments in the home furnishings and apparel markets, including upholstery, linens, activewear and intimate apparel, according to a news release.

The company named Marilyn Werner as a vice president of business development with a focus on apparel in the New York area. Werner was previously an executive vice president at Danskin.

Nano-Tex also named Nicole Nelson as a vice president of business development to head the company’s activewear and intimate apparel initiatives. Nelson was previously at Unifi, where she led product development.

And it named Wendy Riley as a vice president of business development responsible for building and leading home furnishings accounts nationwide. Most recently, Riley was responsible for management of key retail accounts at Newell Rubbermaid.

August 2, 2005 – The members of the Blue Whale Consortium have announced the successful completion of their mission to develop high-performance, cost-effective chip-size wafer-scale packaging (WSP) for system-on-chip (SoC) for handheld devices. Members include Philips Applied Technologies, which also served as the project manager; DEK International (UK); Dimes, a subsidiary of Delft University of Technology (the Netherlands); Shellcase Ltd. (Israel); and TU Berlin (Germany).

The Blue Whale Consortium was created in 2002 with the objective of demonstrating wafer scale packaging concepts for RF SoC and for power devices, as well as to develop equipment for a wafer balling process. This particular project was funded by the IST, the Information Society Technologies Programme of the Fifth Framework Programme of the EC.

SoC solutions, which entail integrating several system functions into one piece of silicon (monolithic integration), avoid the problem of having too high a ratio of the semiconductor area being used for interconnects.

“System-on-Chip is expected to evolve rapidly in the coming years,” said Dr. Co van Veen, who led Philips Applied Technologies’ involvement in the consortium. “By combining a RFCMOS-IC, with mixed functionality potential, and wafer level packaging, we showed that it is possible to achieve a 90% reduction in occupied area on the printed circuit board, compared with the standard QFP solution.”

Contrary to existing single-chip packaging or system-in-package, the Consortium members demonstrated a chip-size wafer-level packaging technology to achieve “true die-size” packaging.

Click here to enlarge image

Aug. 2, 2005 — Today quantum dots shine in the life sciences, where researchers tack them onto molecules in cells and use their fluorescing properties to track their movement. The tags allow scientists to spy on cellular processes and better understand the inner workings of biological systems.

But quantum dot manufacturers have their sights on much larger and more lucrative markets: solar cells, electronics and even diagnostics. Manufacturers have recognized that in order to achieve their goals, though, they’ll need a much different quantum dot than those used in research.

It’s one thing to put potentially toxic nanocrystals in a Petri dish. It’s another to introduce cadmium or other heavy metals found in quantum dots into solar devices, displays and the human body.

In late spring, two companies based in New York independently announced that they had found a solution, one by engineering around the problem and the other by creating a new kind of fluorescing nanoparticle. A third company in California also is working to produce a cadmium-free quantum dot.

“The need has been driven by our customers,” said Clinton Ballinger, chief executive of Evident Technologies in Troy, N.Y. Evident made a quantum dot that contains no heavy metals commercially available in late May. The new line of its EviTags is being targeted at life science researchers who want to use labels within living organisms. But Ballinger said that companies in Japan and Europe also were interested in testing the new line for energy and lighting applications.

“Japan and Europe have a strict limit on cadmium and lead in electronic and optoelectronic devices like displays. They don’t want to have cadmium in those devices,” Ballinger said. Pharmaceutical and other biomedical researchers also worry that cadmium may poison cells in assays.

“In life science applications, the customers question how smart it is to put cadmium in,” he said. “Cadmium kills cells.”

Evident devised a new method for making the nanoparticles that are the core of a quantum dot. Dots, if they are sufficiently small, emit specific colors when exposed to light waves. The size and composition of the dot determines the color. Making dots typically requires two materials such as dimethyl cadmium and selenium.

Evident uses a three-material system instead to produce indium gallium phosphide quantum dots that are then encased in a zinc-metal shell. The shell is designed to bind to the core to produce a bright and long-lasting fluorescence. Evident adds a coating to the shell to make it more stable in water and in harsh environments.

Its near-term goal is to provide dots for life science research. But the company’s mid-term and long-term plans include the larger and more lucrative markets of diagnostics, sensors and eventually light emitting diodes and solar cells. “This is mostly driven by Japan’s optoelectronics,” Ballinger said. “They’ll need more dots than biotech will ever use.”

In the future, customers may have other options as well. Researchers at Cornell University announced in May that they had made a silicon-based nanoparticle that fluoresced like quantum dots. The nanoparticles, which are akin to glass beads with dye in them, were made at room temperature using solvents like water and alcohol rather than heavy metals.

“The advantages clearly are that the synthesis is easy and the conditions are relatively benign,” said Ulrich Wiesner, a professor of materials science and engineering at Cornell. He also is co-founder of Hybrid Silica Technologies, a startup based in Ithaca, N.Y., that intends to commercialize what they’ve named Cornell dots. “It’s a nice approach. … The surface chemistry of silica is well known, so we can functionalize (add onto) them with everything under the sun.”

Wiesner and his team attached dye molecules to a nanoparticle core that is then encased in silica. While that technique is not novel, the Cornell team has been able to use it to make dots in the 20- to 30-nanometer range. Then they mastered a system for making dots of a uniform size and dispersion.

The dots initially produced only a dim light. But when they added the silica shell, “the brightness went through the roof,” Wiesner said. They realized they had a possible substitute for quantum dots when a brightness test showed their dots to be a contender. “Now we hope to close the gap or even exceed it,” he said.

Wiesner, former student Hooisweng Ow and Cornell alumnus Kenneth Wang created Hybrid Silica Technologies in late 2003 and remain in the early stages of building a business. But Wiesner said they already have corporate support and have been approached by companies that see possible uses for their dots. Their next challenge is to develop quality control mechanisms.

In the meantime, Quantum Dot Corp. also is exploring ways to eliminate cadmium from biotech products. The Hayward, Calif.-based company has been involved in medical projects that could lead to diagnostic applications such as a quantum dot-based test for detecting and monitoring diseases of the eye. By removing the potentially toxic cadmium, the company hopes to avoid time-consuming and expensive tests that would be required by the U.S. Food and Drug Administration.

Ballinger and Wiesner agree that the quantum dot industry will benefit from having several suppliers whose products can stand up to customers’ scrutiny. “We can’t have a quantum dot industry without competition,” Ballinger said. “This is new to the end users, and if they only see our company, that doesn’t bode well.”

By Jason Tiffany, Infineon Technologies, Richmond, Virginia, Barney Cohen, SensArray Corp., Fremont, California

As linewidths approach 90nm node in volume production, post exposure bake (PEB) uniformity becomes a much larger component of the across-wafer critical dimension uniformity (CDU). In production, the need for PEB plate matching has led to novel solutions such as plate-specific dose offsets. However, this type of correction does not help across-wafer CDU. A different approach using an in situ wireless RTD wafer is explored.

Due to unequal activation energies of critical PEB processes, any thermal history difference can result in a corresponding CD variation – differences that become more pronounced as the industry moves to manufacturing at the 90nm node. The rise time of the resist to the target temperature has been shown to affect CD, with the most critical time being the first 5-7 sec. A typical PEB plate has multizone thermal control with one thermal sensor per zone….

Read the complete article in a pdf format.

If you have any questions or comments, please contact:
Julie MacShane, Managing Editor, SST at email: [email protected].

July 28, 2005 — Alien Technology, a Morgan Hill, Calif., provider of radio frequency identification (RFID) products made using its proprietary fluidic self assembly process, announced the completion of a $66 million Series H round of financing.

SunBridge Partners led the round. Existing investors Advanced Equities, Digital Bandwidth, Equitek Capital, Lago Ventures and Miami Valley Venture Fund also participated, according to a news release. The round brings the total capital invested in Alien to more than $200 million.

The financing provides the company with capital to expand and pursue new market opportunities. “The success of this latest round of financing underscores investor interest in the RFID arena and reinforces Alien’s ongoing market and technology leadership,” said Stav Prodromou, chief executive officer, in a prepared statement.

Prodromou said the company would continue to invest in new high-volume manufacturing capabilities, advanced product development and expanded customer solution services and facilities. He said that included activities like acquisitions that are intended to broaden market reach.

Alien recently purchased Quatrotec, an integration services and project management firm focused on commercial aviation and other transportation markets. The acquisition was intended to help Alien expand in the baggage tag and reader market.

July 27, 2005 — Advance Nanotech Inc. (OTC BB: AVNA), a provider of financing and support services for nanotech commercialization, announced the appointment of Fred Allen as senior vice president of materials.

Allen will be responsible for managing all of the firm’s partnerships and investments related to materials sciences. He will report directly to Advance Nanotech CEO Magnus Gittins.

Allen previously held a management position in R&D at Engelhard Corp. where he led the technology assessment function and nanotechnology program. He also supported Engelhard’s Ventures Group, where he participated in evaluating commercial opportunities for the firm.

MRSA a leading culprit in thousands of hospital-acquired infections and deaths each year

ENGLEWOOD, Fla.–July 12, 2005 (PRIMEZONE)–SinoFresh HealthCare, Inc. (OTCBB:SFSH) today announced positive results of a controlled laboratory experiment studying the killing effectiveness of SinoFresh(tm) Nasal Spray against the deadly MRSA bacteria in vitro. Dr. Barry Kreiswirth, Ph.D., conducted the study at the Public Health Research Institute (PHRI) of Newark, NJ, where he is director of the Institute’s Tuberculosis Center and Hospital Infections Program.

The results showed 100% killing of an infectious concentration of MRSA virtually upon contact with SinoFresh(tm) Nasal Spray. Methicillin resistant Staphylococcus aureus derives its name from its resistance to commonly used antibiotics. It has become a major problem in hospitals and other extended care facilities where sick patients are particularly susceptible to infection.

William Wilferth, R.Ph., M.S., Vice President of R&D for SinoFresh HealthCare stated, “Through this and previous studies, we’ve now shown in vitro that SinoFresh(tm) eradicates representative strains of the three most common sources of upper respiratory illness — bacteria, viruses, and mold.” He continued, “We are very pleased that Dr. Kreiswirth, whose expertise in the characterization and surveillance of MRSA strains and infections has led to collaborations with the Centers for Disease Control and the National Institutes of Health, was able to provide his support and direction.”

The latest in vitro results will form part of the basis of discussion when SinoFresh HealthCare goes before the U.S. Food and Drug Administration (FDA) for a Pre-Investigational New Drug (Pre-IND) meeting to determine its course of action to gain drug status for a prescription version of SinoFresh(tm) Nasal Spray.

About SinoFresh HealthCare, Inc.

SinoFresh HealthCare, Inc. is a developer and marketer of innovative therapies for conditions of the upper respiratory system. The Company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial, and fungal organisms that are suspected to cause pathogenesis of the mouth, nose, and throat. The Company holds many patents and patent applications on its innovative pharmaceutical technology and relies upon a distinguished panel of medical experts and a management team experienced in the bio-pharmaceutical arena.

The Company’s lead product, SinoFresh(tm) Nasal Spray, is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. The Company is also researching how antiseptic cleansing may aid in alleviating sinus distress, a problem that may affect 37 million Americans annually. SinoFresh(tm) Nasal Spray Care is available nationwide in Wal-Mart, Walgreens, Rite Aid, CVS, Sav-on drugs, Osco Drug and other drug, grocery and mass merchandise retailers. More information is available at www.sinofresh.com

Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements speak only as of the date on which such statements are made and involve risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission, including risks summarized in the Company’s Annual Report on Form 10-KSB for its fiscal year ended December 31, 2004 (file No. 0-49764). The Company’s actual results could differ materially from such forward-looking statements. The Company undertakes no obligation to update any forward-looking statement or statements to reflect new events or circumstances or future developments.

SinoFresh(tm) is a trademark of SinoFresh HealthCare, Inc.

CONTACT: SinoFresh HealthCare, Inc.
Michael Gillette
(941) 681-3121

Investor Relations:
(941) 681-3135

July 12, 2005 – Brooks Automation Inc., Chelmsford, MA, plans to acquire Helix Technology Corp., Mansfield, MA, for $454 million in stock, creating a company with combined trailing revenues of $720 million with strong complementary offerings in vacuum modules and systems businesses.

The combined company, to be known as Brooks Automation and owned 61% by Brooks, will be led by Brooks president and CEO Edward Grady. Helix president and CEO James Gentilcore will join a new Office of the President as president/COO of a new semiconductor products group, while Joseph Bellini, EVP and GM of Brooks’ software division, would be president and COO of an enterprise software group. The transaction is expected to close in 4Q05.

Completion of the transaction is subject to customary closing conditions, and is expected to occur in the fourth calendar quarter of 2005.